Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

Alicia M. Fry(National Center for Immunization and Respiratory Diseases), W. Abdullah Brooks(Johns Hopkins University), Tasnim Azim(International Centre for Diarrhoeal Disease Research), Doli Goswami, Kamrun Nahar(International Centre for Diarrhoeal Disease Research), Joseph Bresee(National Center for Immunization and Respiratory Diseases), Amina Tahia Sharmin(International Centre for Diarrhoeal Disease Research), Larisa V. Gubareva(Centers for Disease Control and Prevention), Stephen P. Luby(Centers for Disease Control and Prevention), Mustafizur Rahman(Infectious Disease Research Institute)
The Lancet Infectious Diseases
November 22, 2013
10.1016/s1473-3099(13)70267-6
Cited by 142

Related Papers

Food-Related Illness and Death in the United States
|Emerging infectious diseases|1999|7.3k
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3k
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
|New England Journal of Medicine|2009|1.7k
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
|The Lancet|2011|999